Author:
Wang Qun,Lv Hongchao,Lv Wenhua,Shi Miao,Zhang Mingming,Luan Meiwei,Zhu Hongjie,Zhang Ruijie,Jiang Yongshuai
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Kovac JR, Pan MM, Lipshultz LI, Lamb DJ. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids. 2014;89:27–32.
2. Gallagher RP, Fleshner N. Prostate cancer: 3. Individual risk factors. CMAJ. 1998;159:807–13.
3. Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat. 2014;17:13–23.
4. Dinkel A, Kornmayer M, Gschwend JE, Marten-Mittag B, Herschbach P, Herkommer K. Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors. Familial Cancer. 2014;13:481–8.
5. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomark Prev : Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2003;12:665–8.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献